Company: LIMN
Filing Date: 2025-02-07
Form Type: 424B3
Source: 0001104659-25-010605
Chunk: 708

Company: Liminatus Pharma, Inc.
Filing Date: 2025-02-07
Form: 424B3
Chunk 708
---
 Existing Certificate ”).

2. This Amended and Restated Certificate of Incorporation (the “ Amended and Restated Certificate ”), which amends and restates the Existing Certificate in its entirety, has been approved by the Board of Directors of the Corporation (the “ Board of Directors ”) in accordance with Sections 242 and 245 of the DGCL and has been adopted by the stockholders of the Corporation at a meeting of the stockholders of the Corporation in accordance with the provisions of Section 211 of the DGCL.

4. The text of the Existing Certificate is hereby amended and restated by this Amended and Restated Certificate to read in its entirety as set forth in EXHIBIT A attached hereto.

5. This Amended and Restated Certificate shall become effective on the date of filing with the Secretary of State of the State of Delaware.

IN WITNESS WHEREOF, Iris Parent Holding Corp. has caused this Amended and Restated Certificate to be signed by a duly authorized officer of the Corporation, on , 2024.

#### IRIS PARENT HOLDING CORP.
By:

Name:

Title:

Chief Executive Officer

<div align='center'>[Signature Page to Amended and Restated Certificate of Incorporation]

C-1</div>

TABLE OF CONTENTS

#### Exhibit A

### ARTICLE INAME
The name of the corporation is Liminatus Pharma, Inc. (the “Corporation”).

### ARTICLE IIREGISTERED OFFICE AND AGENT
The address of the Corporation’s registered office in the State of Delaware is c/o Corporation Service Company, 251 Little Falls Drive in the city of Wilmington, County of New Castle, 19808, and the name of its registered agent at such address is Corporation Service Company.

### ARTICLE IIIPURPOSE
The purpose of the Corporation is to engage in any lawful act or activity for which corporations may be organized under the General Corporation Law of the State of Delaware (the “DGCL”) as it now exists or may hereafter be amended and supplemented.

### ARTICLE IVCAPITALIZATION
Section 4.1 Authorized Capital Stock . The total number of shares of all classes of capital stock, each with a par value of $0.0001 per share, which the Corporation is authorized to issue is 501,000,000 shares, consisting of (a) 500,000,000 shares of common stock (the “

#### Common Stock
”), and (b) 1,000,000 shares